Point72 Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,482
Closed -$1.08M 4444
2026
Q1
$1.08M Sell
19,482
-14,373
-42% -$684K ﹤0.01% 2721
2025
Q4
$1.26M Buy
+33,855
New +$1.38M ﹤0.01% 2749
2025
Q2
Sell
-27,443
Closed -$586K 2491
2025
Q1
$586K Buy
+27,443
New +$613K ﹤0.01% 1583
2023
Q4
Sell
-66
Closed -$837 2651
2023
Q3
$837 Buy
+66
New +$936 ﹤0.01% 2371

Other funds holding PAHC

Point72 Asset Management's PAHC Position: Q2 2026 in Review

Point72 Asset Management sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 19,482 shares — an estimated $1.08M sold.

Point72 Asset Management first reported a position in PAHC in Q3 2023 and held it in 4 quarters. The position peaked at $1.26M in Q4 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Point72 Asset Management reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 19,482 Phibro Animal Health shares in Q2 2026, an estimated $1.08M.
  • Point72 Asset Management first reported a position in Phibro Animal Health in Q3 2023 and held it in 4 quarters.
  • Point72 Asset Management's Phibro Animal Health position peaked at $1.26M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.